ağrı med j

Ağrı Tıp Fakültesi Dergisi

2980-0978

Ağrı İbrahim Çeçen Üniversitesi

10.61845/agrimedical.1782782

Allergy

Alerji

Chronic spontaneous urticaria: Current approaches and the importance of awareness

Kronik spontan ürtiker: Güncel yaklaşımlar ve farkındalığın önemi

https://orcid.org/0000-0002-0810-087X

Cihanbeylerden

Melek

HACETTEPE UNIVERSITY

10 29 2025

3 3 158 159 09 12 2025 10 24 2025

2023

Ağrı Tıp Fakültesi Dergisi

Since this manuscript is a letter to the editor, no abstract is required in accordance with the journal’s instructions for authors.

Bu makale editöre mektup niteliğindedir ve derginin yazarlara yönelik talimatları uyarınca özet gerektirmemektedir.

Anjioödem Antihistaminik Mast hücresi Omalizumab Siklosporin Ürtiker

Angioedema Antihistamine Cyclosporine Mast cell Omalizumab Urticaria

Kocatürk E, Chu DK, Türk M, et al. Management of chronic spontaneous urticaria made practical: what every clinician should know. J Allergy Clin Immunol Pract. 2025;13(9):2252-2269.

Zuberbier T, Ensina LF, Giménez-Arnau A, et al. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalized treatment. Lancet. 2024;404(10450):393-404.

Kolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-31.

Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766.

Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365-72.e6.

Xiao X, Xue P, Shi Y, et al. The efficacy and safety of high-dose non-sedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials. BMC Pharmacol Toxicol. 2023;24(1):23.

Maurer M, Rosén K, Hsieh H-J, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924-35.

Soegiharto R, Aghdam MA, Sørensen JA, et al. Multinational drug survival study of omalizumab in patients with chronic urticaria and potential predictors for discontinuation. JAMA Dermatol. 2024;160(9):927-35.

Türk M, Kocatürk E, Ertaş R, et al. A global perspective on stepping down chronic spontaneous urticaria treatment: results of the Urticaria Centers of Reference and Excellence SDown-CSU study. Clin Transl Allergy. 2024;14(2):e12343.

Kulthanan K, Chaweekulrat P, Komoltri C, et al. Cyclosporine for chronic spontaneous urticaria: a meta-analysis and systematic review. J Allergy Clin Immunol Pract. 2018;6(2):586-99.